Literature DB >> 8851490

A study of tolerance to apomorphine.

J L Montastruc1, M E Llau, J M Senard, M A Tran, O Rascol, P Montastruc.   

Abstract

1. The present study was designed to investigate tolerance to several pharmacological effects of apomorphine. 2. Changes in blood pressure, heart rate, plasma noradrenaline levels, rectal temperature, respiratory rate and retching plus vomiting were compared after administration of apomorphine (200 micrograms kg-1, i.v. as a bolus) or saline at different time intervals (30, 120 and 720 min) in four groups of chloralose-anaesthetized dogs. 3. The first administration of apomorphine induced a significant decrease in blood pressure and rectal temperature, a marked rise in heart rate with no change in noradrenaline plasma levels or respiratory rate. Emesis occurred in 71% of the animals. 4. A second administration of apomorphine 30 min later failed to modify blood pressure or heart rate. In contrast, the magnitude of apomorphine-induced changes in blood pressure and heart rate was similar to that observed after the first administration when apomorphine was given 120 or 720 min later. 5. The apomorphine-induced decrease in rectal temperature evoked by a second dose of apomorphine was less marked when given 30 and 120 min after the first dose and unchanged when given 720 min later. 6. The number of animals exhibiting retching and vomiting was lower when apomorphine was reinjected after 30 min than when the time between two successive injections of apomorphine was 120 or 720 min. 7. These results show that tolerance to apomorphine involves its cardiovascular, hypothermic and emetic effects. The time course of tolerance to repeated injections of apomorphine is longer for its hypothermic than for its hypotensive or emetic effects. This suggests a tissue-specific regulation of D2 dopamine receptors to repeated injections of apomorphine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851490      PMCID: PMC1909420          DOI: 10.1111/j.1476-5381.1996.tb15260.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Apomorphine: chemistry, pharmacology, biochemistry.

Authors:  F C Colpaert; W F Van Bever; J E Leysen
Journal:  Int Rev Neurobiol       Date:  1976       Impact factor: 3.230

2.  Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice.

Authors:  J Costentin; D Duterte-Boucher; C Panissaud; A Michael-Titus
Journal:  Neuropharmacology       Date:  1990-01       Impact factor: 5.250

Review 3.  Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.

Authors:  J L Willems; W A Buylaert; R A Lefebvre; M G Bogaert
Journal:  Pharmacol Rev       Date:  1985-06       Impact factor: 25.468

4.  Motor response following repeated apomorphine administration is reduced in Parkinson's disease.

Authors:  F Grandas; J A Obeso
Journal:  Clin Neuropharmacol       Date:  1989-02       Impact factor: 1.592

5.  Cardiovascular effects of apomorphine in humans: evidence for peripheral mechanisms.

Authors:  O J Rascol; J L Montastruc
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

6.  Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.

Authors:  J L Montastruc; C Guiol; M A Tran; F Lhoste; P Montastruc
Journal:  Arch Int Pharmacodyn Ther       Date:  1985-09

Review 7.  Dopamine receptor subtypes: beyond the D1/D2 classification.

Authors:  P H Andersen; J A Gingrich; M D Bates; A Dearry; P Falardeau; S E Senogles; M G Caron
Journal:  Trends Pharmacol Sci       Date:  1990-06       Impact factor: 14.819

8.  Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

Authors:  R Castro; P Abreu; C H Calzadilla; M Rodriguez
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Peripheral pharmacokinetics of apomorphine in humans.

Authors:  S T Gancher; W R Woodward; B Boucher; J G Nutt
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

10.  Apomorphine infusional therapy in Parkinson's disease: clinical utility and lack of tolerance.

Authors:  S T Gancher; J G Nutt; W R Woodward
Journal:  Mov Disord       Date:  1995-01       Impact factor: 10.338

View more
  1 in total

Review 1.  The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Drugs R D       Date:  2018-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.